Richard Butterworth didn’t set out to build a global health technology company. He set out to solve a problem that had been hiding in plain sight for decades: the silent epidemic of undiagnosed respiratory disease in performance horses, and the complete absence of a drug-free, repeatable therapy to treat it. The result is Equine Salt Therapy, a patented dry salt delivery system that has created an entirely new category in equine wellness. This is the story of how a single insight, combined with years of industry experience and a relentless focus on intellectual property, has positioned an Australian business for international scale.
Table of Contents
-
The Founder’s Vision – Why Richard Butterworth Built a New Category
-
The Global Equine Industry Opportunity – A $300 Billion Market Gap
-
The Evolution of the Technology – From Prototype to Proven System
-
The Licensing and Business Model – How EST Scales Without Owning Barns
-
International Expansion Strategy – Australia First, Then the World
-
Financial Opportunity and Valuation – The Numbers That Matter
-
Potential Strategic Buyers – Who Would Acquire Equine Salt Therapy?
The Founder’s Vision – Why Richard Butterworth Built a New Category
Richard Butterworth spent years immersed in the Australian equine industry, working alongside trainers, vets, and stable managers. What he saw troubled him. Horses were being treated repeatedly with mucolytics and corticosteroids for respiratory issues that never quite resolved. Many were labelled as poor performers when the real culprit was undiagnosed Lower Airway Disease, a condition that saps oxygen uptake and stamina without always producing obvious symptoms. The pharmaceutical approach was expensive, invasive, and came with side effects. There had to be a better way.
The breakthrough came when Butterworth connected the established research on human halotherapy, dry salt aerosol inhalation used for respiratory conditions, with the unmet needs of equine athletes. No one had successfully adapted the science for horses in a controlled, repeatable, and clinically credible format. The founding principle was clear from day one: build a therapy that is 100 percent drug-free, treats both respiratory and skin conditions simultaneously, and can be delivered consistently across any location. What began as a single treatment room has evolved into a scalable, licensable global platform that is now attracting attention from investors and strategic buyers alike.
The Global Equine Industry Opportunity – A $300 Billion Market Gap
The global equine industry is valued at approximately $300 billion annually, with the performance horse health and wellness segment representing a significant and growing share. Within that segment, respiratory disease is the second most common cause of lost training days, trailing only musculoskeletal injury. A UK study on racehorses found that a startling proportion of horses flagged as underperforming were actually suffering from undiagnosed Lower Airway Disease, a condition that responds poorly to environmental management alone and often recurs after pharmaceutical treatment ends.
The cost of L.A.D. is measured not just in vet bills but in missed race days, abandoned training blocks, and careers cut short. Owners and trainers across Australia, the UK, and North America are increasingly seeking natural, drug-free alternatives that can be integrated into daily stable routines without withdrawal periods or regulatory complications. Existing solutions, mucolytics, steroids, nebulised bronchodilators, and dust-control measures, each address part of the problem but none offer a non-invasive, repeatable therapy that clears the airways and heals the skin in a single session. That is the gap Equine Salt Therapy was built to fill.
The Technology – Patented Dry Salt Delivery and Ultisalt™
At the heart of Equine Salt Therapy is the halo-generator, a purpose-built device that micronises pharmaceutical-grade salt into a dry aerosol of particles small enough to penetrate the lower airways. This is not a salt lick, not a humidified saline mist, and not a room lined with Himalayan salt bricks. The halo-generator creates a precisely controlled microclimate inside a sealed treatment space, whether a permanent salt room or a mobile trailer, delivering a consistent concentration of respirable particles for the duration of each session.
The salt itself is equally critical. Ultisalt™ is a proprietary formulation developed specifically for equine physiology. Its particle size distribution, mineral composition, and flow characteristics have been optimised through years of real-world testing with horses ranging from yearlings to seasoned Group 1 performers. The therapy works through a dual mechanism: inhaled particles stimulate the mucociliary escalator, the airway’s natural clearance system, thinning mucus and triggering expectoration, while topical contact with the skin treats conditions like mud fever, rain rot, and dermatitis. The patent protects the integrated delivery system, the generator design, and the Ultisalt™ composition, creating a defensible moat that no competitor can easily replicate.
The Patent and Intellectual Property Strategy
The intellectual property portfolio is the foundation of the entire business. Equine Salt Therapy holds patents covering the dry salt delivery system, the halo-generator design, and the Ultisalt™ formulation. These are not vague process patents; they are specific, enforceable protections that prevent copycat operators from entering the market with lookalike equipment and generic salt.
For a licensing-based business model, IP is everything. It gives licensees confidence that their territory is protected. It adds tangible value to the balance sheet. It enables the company to negotiate master franchise agreements with clear territorial rights. The patent strategy began with Australian filings, reflecting the beachhead market and the location of the founding R&D, and has since expanded to cover the UK, the USA, and key racing jurisdictions. The “world-first” claim is not marketing hyperbole; it is backed by a deliberate, multi-jurisdictional IP strategy that underpins the brand’s credibility with vets, trainers, and investors.
The Evolution of the Technology – From Prototype to Proven System
The early R&D phase was grounded in Victoria, where Butterworth worked directly with local trainers willing to trial the prototype on their horses. Feedback was immediate and instructive. Horses that had been scoping poorly showed visible clearance after just a few sessions. Trainers reported faster recovery times post-race and a noticeable reduction in coughing during exercise. The connection to Peter Moody and the legendary Black Caviar brought national attention, but it was the consistent, repeatable results across dozens of stables that validated the technology.
Each iteration of the halo-generator refined the particle size control and the delivery consistency. The Ultisalt™ formulation was adjusted based on observed outcomes, with particular attention to horses in humid coastal environments versus dry inland conditions. The shift from a single-site service to a replicable, turnkey system was the pivotal strategic move. Instead of building more rooms itself, the company invested in making the technology installable, trainable, and supportable anywhere in the world.
The Licensing and Business Model – How EST Scales Without Owning Barns
Equine Salt Therapy does not own or operate salt rooms. The company licenses the technology, equipment, and Ultisalt™ supply to practitioners: equine vets, physiotherapists, stable owners, and existing therapy centres. This model is capital-light, fast to scale, and generates recurring revenue from consumables rather than one-off equipment sales.
The licensee value proposition is straightforward. Practitioners receive a proven system with documented results, brand recognition built on high-profile endorsements, comprehensive training, and ongoing technical support. They are not buying a machine; they are buying into a category-defining brand with a protected territory. The model operates on two tiers: permanent salt rooms for large training centres and major equine hospitals, and mobile units that bring the therapy to regional stables, agistment centres, and competition venues. The mobile option is particularly attractive in Australia, where the equine population is geographically dispersed and many owners cannot travel hours to a fixed installation. For those interested in the mobile pathway, the business opportunity is structured to be accessible without prior therapy experience, as outlined in the company’s guide to operating a mobile salt therapy business and living the dream.
The Practitioner Ecosystem – Who Delivers the Therapy
The ideal licensee is already embedded in the equine health ecosystem. Equine vets see the respiratory cases that need ongoing management. Physiotherapists and bodyworkers understand the connection between respiratory efficiency and musculoskeletal performance. Stable managers want a competitive edge in horse welfare that attracts and retains owners. EST provides a structured training and certification process that ensures every licensed practitioner delivers the therapy to the same standard, regardless of location.
Veterinary endorsements have been critical to building trust within the professional community. When a respected equine vet like Christopher Elliott advocates for the therapy, it signals to the broader industry that this is not a fringe alternative but a legitimate clinical tool. The ecosystem creates a natural network effect: each new practitioner treats more horses, more owners see the results, and demand for licensed providers grows organically.
Products and Recurring Revenue – Beyond the Salt Room
The business generates revenue through three channels. The first is the upfront licence and equipment fee, which covers the halo-generator, installation, training, and territory rights. The second, and most valuable over time, is the recurring sale of Ultisalt™ consumables. Every treatment session consumes fresh Ultisalt™, creating a predictable, high-margin revenue stream that grows in direct proportion to the number of active licensees and the frequency of treatments they deliver. The third channel is ongoing support, technology upgrades, and advanced training.
This consumables model is the engine of the company’s valuation. It transforms a capital equipment sale into an annuity, and it aligns the company’s success with the licensee’s success: both parties benefit when more horses are treated more often. Future product lines under consideration include smaller, stable-side units for individual horse use and complementary wellness products that extend the brand into adjacent categories. The recurring revenue architecture is precisely what strategic buyers look for when evaluating acquisition targets.
International Expansion Strategy – Australia First, Then the World
Australia is the natural beachhead. The country has a deep racing culture, a large population of performance and pleasure horses, and an established network of high-profile trainers who have already endorsed the therapy. The domestic market provides proof of concept, reference sites for international prospects, and a base of recurring revenue that funds expansion.
The next wave targets the UK and Ireland, where the equestrian tradition is centuries old and the existing interest in mobile salt therapy, visible in services like Yorkshire Equine Salt Therapy, confirms demand. The regulatory environment is favourable, and the racing and eventing circuits provide dense concentrations of target horses. Beyond that, the strategy targets the USA, the world’s largest equine market, followed by New Zealand and the Middle Eastern racing hubs. The licensing model supports a master franchisee structure in each territory, where a local partner with industry relationships manages sub-licensees and distribution, reducing the operational burden on the Australian headquarters.
Financial Opportunity and Valuation – The Numbers That Matter
The unit economics of a licensed salt room are compelling. A licensee’s setup cost is recovered through treatment fees, with typical payback periods that compare favourably to other equine capital investments like solariums or water treadmills. The addressable market is substantial: Australia alone has tens of thousands of performance horses, and when multiplied by a conservative treatment frequency of one protocol cycle per month during the racing or competition season, the recurring Ultisalt™ revenue becomes significant.
Valuation drivers for the company include the strength of the IP portfolio, the size and growth rate of the recurring revenue base, the number and geographic spread of licensees, and the brand equity anchored by the Black Caviar association. Comparable human wellness franchises, think float tank studios and cryotherapy chains, have achieved exit multiples in the range of 6 to 12 times revenue when they demonstrate defensible IP and recurring consumables revenue. Equine Salt Therapy sits at the intersection of animal health, wellness franchising, and proprietary technology, a combination that attracts premium valuations.
Potential Strategic Buyers – Who Would Acquire Equine Salt Therapy?
The company’s profile makes it a natural acquisition target for several categories of buyer. Animal health and pharmaceutical companies like Zoetis, Elanco, and Boehringer Ingelheim are actively seeking non-pharmaceutical assets to diversify their portfolios as the industry shifts toward drug-free alternatives. An acquisition would give them an immediate entry into the equine wellness space with a patented, revenue-generating platform.
Equestrian equipment and feed companies, including the likes of Weatherbeeta or global nutrition brands, could add a high-tech service line with recurring revenue to their existing product businesses. Wellness and therapy franchise groups that currently focus on humans may see an equine vertical as a logical extension of their brand. Private equity firms, meanwhile, are drawn to the combination of defensible IP, recurring revenue, and a clear international growth runway. Each of these buyer profiles values a different aspect of the business, which strengthens the company’s negotiating position when the time comes.
Horse Welfare and the Future Vision – Beyond Performance
The ultimate mission of Equine Salt Therapy extends beyond race wins and prize money. The goal is to improve the quality of life for every horse, from the elite athlete to the retired companion. Chronic respiratory and skin conditions affect horses across all disciplines and all stages of life. A drug-free therapy that can be delivered without stress, without needles, and without withdrawal periods represents a genuine advance in equine welfare.
The vision is a global network of licensed EST centres where any horse owner can access the therapy, whether through a fixed room at a major equine hospital or a mobile unit that visits their local agistment centre. As the equine industry continues its broader shift toward natural, evidence-based care, Equine Salt Therapy is positioned not just as a commercial success story but as a meaningful contributor to the health and longevity of horses everywhere. The technology is protected, the model is proven, and the mission is just beginning.
Frequently Asked Questions
What is Equine Salt Therapy, and how does it work?
Equine Salt Therapy uses a patented halo-generator to micronise a proprietary salt formulation called Ultisalt™ into a dry aerosol inside a sealed treatment space. The horse inhales the microscopic particles, which travel deep into the airways to thin mucus and stimulate natural clearance, while the salt that settles on the skin treats topical conditions. The technology is explained in more detail on the company’s technology page.
Is Equine Salt Therapy safe for all horses?
The therapy is drug-free, non-invasive, and has been used safely on thousands of horses ranging from yearlings to seasoned racehorses. There are no known contraindications for the vast majority of horses. As with any new therapy, owners of horses with pre-existing heart conditions or other serious health issues should consult their veterinarian before beginning treatment.
How long does a typical treatment session take?
The standard protocol is 15 minutes per day for three consecutive days. This protocol can be repeated as needed, with many trainers incorporating it into their pre-race preparation and post-race recovery routines.
Can salt therapy treat both respiratory and skin conditions at the same time?
Yes. The dual mechanism of action is one of the therapy’s defining advantages. Inhaled particles work on the respiratory system while topical contact treats skin conditions like mud fever, rain rot, and dermatitis simultaneously.
Where can I find a licensed Equine Salt Therapy practitioner?
Visit the Equine Salt Therapy website to enquire about licensed practitioners in your area or to explore becoming a licensee yourself.
